Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) — Financial Flexibility Index
Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥80.76 Million (operating CF CN¥76.07 Million minus capex CN¥4.69 Million) represents 0% of total liabilities (CN¥1.05 Billion). Also explore Beijing Sun Novo Pharmaceutical Research annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Beijing Sun Novo Pharmaceutical Research Co Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Beijing Sun Novo Pharmaceutical Research Co Ltd across 8 annual periods. Check 688621 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Beijing Sun Novo Pharmaceutical Research Co Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for Beijing Sun Novo Pharmaceutical Research Co Ltd. For the full company profile including market capitalisation, see 688621 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.07x | CN¥62.50 Million | CN¥32.02 Million | CN¥884.65 Million | ▼ -65.7% |
| 2023 | 0.21x | CN¥165.82 Million | CN¥92.86 Million | CN¥805.76 Million | ▼ -45.1% |
| 2022 | 0.37x | CN¥207.83 Million | CN¥103.96 Million | CN¥554.86 Million | ▲ +2.3% |
| 2021 | 0.37x | CN¥173.21 Million | CN¥88.25 Million | CN¥473.01 Million | ▼ -21.9% |
| 2020 | 0.47x | CN¥90.03 Million | CN¥62.99 Million | CN¥191.94 Million | ▼ -5.4% |
| 2019 | 0.50x | CN¥82.64 Million | CN¥56.97 Million | CN¥166.76 Million | ▲ +4.6% |
| 2018 | 0.47x | CN¥60.52 Million | CN¥44.11 Million | CN¥127.68 Million | ▲ +25.7% |
| 2017 | 0.38x | CN¥28.97 Million | CN¥8.01 Million | CN¥76.82 Million | — |